Argentina In Vivo Cro Market Size & Outlook, 2024-2030
Related Markets
Argentina in vivo cro market highlights
- The Argentina in vivo cro market generated a revenue of USD 29.2 million in 2023 and is expected to reach USD 43.5 million by 2030.
- The Argentina market is expected to grow at a CAGR of 5.9% from 2024 to 2030.
- In terms of segment, small molecule was the largest revenue generating modality type in 2023.
- Large Molecule is the most lucrative modality type segment registering the fastest growth during the forecast period.
In vivo cro market data book summary
| Market revenue in 2023 | USD 29.2 million |
| Market revenue in 2030 | USD 43.5 million |
| Growth rate | 5.9% (CAGR from 2023 to 2030) |
| Largest segment | Small molecule |
| Fastest growing segment | Large Molecule |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
| Key market players worldwide | IQVIA Holdings Inc, JSR Corp, Taconic Biosciences, Evotec SE, Janvier Labs, Charles River Laboratories International Inc, Icon PLC, Labcorp Holdings Inc, PAREXEL, GemPharmatech, PsychoGenics, Biocytogen, SMO-Group |
Other key industry trends
- In terms of revenue, Argentina accounted for 0.6% of the global in vivo cro market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil in vivo cro market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 146.0 million by 2030.
Small molecule was the largest segment with a revenue share of 63.7% in 2024. Horizon Databook has segmented the Argentina in vivo cro market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
The Ministry of Health and the National Administration of Drugs, Food and Medical Devices (ANMAT) are making numerous efforts to increase clinical research & trial activities in Argentina. Moreover, ANMAT, in 2017, reduced the timelines for approval of clinical trials from 160 to 70 business days, modifying the Provision Nº 6677/10 that governs clinical research in Argentina. This is expected to propel the in vivo CRO market during the forecast period.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In Vivo CRO Market Scope
In Vivo CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Argentina in vivo cro market size, by modality type, 2018-2030 (US$M)
Argentina In Vivo CRO Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
